“Big data” analysis reveals new targets for treating ovarian cancer
A recent study led by Hidenori Machino at the RIKEN Center for Advanced Intelligence Project…
Browsing: ovarian cancer
One more step towards treatment of PARP inhibitor-resistant ovarian cancers
A new editorial paper was published in Oncotarget’s Volume 14 on December 22, 2023, entitled, “One more step…
New Peter Mac study shows innovative drug can stop cancer growth
A new Peter Mac study using a pioneering drug has successfully controlled the growth of…
Study reports progress in long-term protection against ovarian cancer tumours
Investigators from the C.S. Mott Center for Human Growth and Development at the Wayne State…
Ovarian cancer: Artificial intelligence predicts therapy responses
A model based on artificial intelligence is able to predict the therapy outcome (measured by…
Predicting cancer patient response to drugs that block DNA repair
Testing for genetic biomarkers can predict which cancer patients are likely to benefit from DNA…
Novel molecule disrupts ovarian and breast cancer growth in animal models
Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can…
Researchers develop blood test for early-stage ovarian cancer
High-grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer. It is…
Combination of cancer vaccine and T cell therapy benefits patients with advanced ovarian cancer
A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with…
Ovarian cancer is not ovarian cancer
Dr Ian Nisbet and Kathy Skoff recently attended an ovarian cancer symposium in Sydney, organised…